News

Acacia Pharma announces positive results from a pivotal phase 3 trial of Baremsis™ for the treatment of post-operative nausea & vomiting

Inside Dr. Doug Melton and Semma Therapeutics’ effort to cure diabetes with stem cells

PatientPing partners with UMass Memorial for better interoperability

Editing out pesticides using CRISPR technology?

Recurly report offers insights on subscription retail programs

Codeship secures $7 million in Series A funding

Flywire CEO Mike Massaro on cross-border payments

Toast launches self-serve kiosks

Harvard Business Review

Personalized recommendation engines like Iora Health are coming to health care

US HealthVest announces $50 Million in Series B round funding to expand behavioral and mental health coverage

F-Prime Capital ranked #2 in top 100 biotech VCs

Stem cell factory opens door for trials of personalized diabetes treatment

Tradier names noted fintech industry leader Stephen Ehrlich as its new CEO

TradeBlock provides Cumberland Mining with Order Management, Execution Tool

Iora Health named an innovator in primary care

Flywire launches cross-border payment service in Japan

Vermont to employ PatientPing to coordinate care

Acacia Pharma initiates second phase e treatment trial with BAREMSIS™, expects NDA filing in 2016

VitalWare Completes Financing to Accelerate Growth of SaaS Solutions for Healthcare Providers

Baxalta and Precision BioSciences form Global Genome Editing Collaboration in Immuno-Oncology

New York Startup, Quartet Health, Finds the Right Algorithm for Mental Health

Steward ACO Picks Quartet Health for Behavioral Health IT

Eris Launches Major Expansion of Standard Swap Futures

Recurly Reports Holiday Season was Exponentially Successful for Subscription Companies

USHealthVest’s Chicago Behavioral Hospital launches center for veterans’ mental health

TraceLink Announces NEXUS ’16: Mastering Global Traceability with a Digital Supply Chain Network

Aclaris Therapeutics Initiates Phase 3 Clinical Trials Of A-101 For The Treatment Of Seborrheic Keratosis

TraceLink Boosts Leadership Position as Proven Track and Trace Network Exceeds 200,000

In specialized cross-border payments space, Flywire expands from universities to hospitals

Trivitron patents NeoMass AAAC kit for newborn screening to detect 50 inborn disorders

Stride Health Partners With Beam Dental To Redesign Dental Care For Self-Employed Americans

Liazon Named Winner Of Fall 2015 Digital Health Awards

BBVA Compass Teams Up With Robo FutureAdvisor

Surface Oncology Partners with Novartis in $170M Deal to Pursue Next-Gen Cancer Immunotherapies

World’s First MRIdian Center Celebrates Two Years of MRI-Guided Radiation Treatments

Ironwood Pharmaceuticals Details Strategy To Build Top-Performing Commercial Biotechnology Company

Ivenix Appoints MedTech Industry Veteran Stuart A. Randle as Chief Executive Officer

Procured Health Reports Significant Growth in 2015

Blueprint Medicines Strengthens Executive Leadership Team

Acacia Pharma reports positive results from study of BAREMSIS™

Nuance’s Dragon Drive Powers New Conversational In-Car Infotainment

Codeship Announces Integration with Amazon EC2 Container Registry

Blueprint Medicines Added to NASDAQ Biotechnology Index

Unum Therapeutics Announces Recombinant DNA Advisory Committee’s (RAC) Unanimous Approval of Phase 1 Study Protocol to Evaluate ACTR Cell Therapy in Non-Hodgkin Lymphoma

Ping Identity Accelerates Disruption of Legacy Web Access Management Solutions as More Enterprises Embrace Cloud and Mobility

Dimension Therapeutics Reports Recent Corporate Progress and Third Quarter 2015 Financial Results

Codeship Raises Another $1.5 Million

Acacia Pharma: Dr Patrick Vink to Succeed Ian Kent as Non-Executive Chairman

Tetraphase Pharmaceuticals to Present at Oppenheimer 26th Annual Healthcare Conference

Tradier Reaches Milestone of 100 Financial Services Firms Integrating Directly with its Brokerage Platform

Blueprint Medicines and PatientCrossroads Launch Registry for Mastocytosis Patients to Increase Understanding of Disease and Speed Therapeutic Development

Mersana Therapeutics to Present Poster at the 2015 San Antonio Breast Cancer Symposium

TraceLink, Roche and SPI Win GS1 Brazil Automation Award for RDC 54 Compliance Pilot

ViewRay® to Present at the LD Micro “Main Event” Microcap Conference

Proteostasis Therapeutics, Inc. Demonstrates Therapeutic Potential of a Proprietary Triple Combination Therapy for the Treatment of Cystic Fibrosis that Restores Activity of Mutant F508del CFTR Protein to 80% of Normal

Aclaris Therapeutics Reports Third Quarter 2015 Financial Results

PatientPing Announces $9.6M in Funding from Google Ventures, F-Prime Capital, and First Round to Build the First National Care Coordination Network

Semma Therapeutics Acquires Providence Biotech Company, CytoSolv, Inc.

TraceLink Ranked Number 293 Fastest Growing Company in North America on Deloitte’s 2015 Technology Fast 500(TM)

Tetraphase Pharmaceuticals to Provide Corporate Update at Stifel 2015 Healthcare Conference

ViewRay to Present at the Stifel 2015 Healthcare Conference

Ultragenyx to Present at Upcoming Investor Conferences

FORUM Pharmaceuticals Inc. Announces Removal of Partial Clinical Hold on Phase 3 Encenicline Program for Cognitive Impairment in Schizophrenia

WuXi PharmaTech and Lilly Announce Strategic Collaboration to Develop Novel Therapeutic in China

Tradier and Equities Lab Partner to Provide University Students with Real-World Trading Experiences

Dimension Therapeutics Announces Expansion of Internal Research and Process Development Capabilities

WuXi PharmaTech Launches Medical Device Testing Services in China

Dimension Therapeutics Announces Pricing of Initial Public Offering

ViewRay’s MRI-Guided Radiation Therapy System Receives Korean Regulatory Marketing Approval

ownCloud Unveils First and Only Flexible Hybrid Cloud Enterprise File Sync & Share Solution with on-Premise Control Plane

WuXi PharmaTech Receives 2015 Asian CRO Company of the Year Award from Frost & Sullivan

Kensho Technologies Inc. Honored by Goldman Sachs for Entrepreneurship – Daniel Nadler Among 100 Most Intriguing Entrepreneurs at 2015 Builders + Innovators Summit

Procured Health Announces Johns Hopkins Health System As New Client

Aclaris Therapeutics International and Rigel Sign License Agreement for JAK Inhibitors to Treat Skin Disorders

Aclaris Therapeutics Announces Pricing of Initial Public Offering

Proteostasis Therapeutics Announces Presentation of Data For Its CFTR Amplifier for Cystic Fibrosis

Ultragenyx Announces Aceneuramic Acid Prolonged Release Marketing Authorization Application Filed and Accepted for Review by European Medicines Agency

Collaboration for Alzheimer’s Prevention: An Initiative to Advance Alzheimer’s Disease Research

Flywire acquires UK-based tuition start-up competitor

peerTransfer expands, rebrands as Flywire

Quartet Health founder and CEO Arun Gupta on tech driving collaboration in behavioral health

Kyruus Gets $25M More for “Moneyball” Approach to Doctors and Patients

Aclaris Therapeutics International and Rigel Pharmaceuticals Sign License Agreement for JAK Inhibitors to Treat Skin Disorders

Blueprint Medicines Receives FDA Authorization to Advance Novel Drug Candidate into Clinical Trial for Systemic Mastocytosis

Proteostasis Therapeutics, Inc. Raises $37 Million in Crossover Financing

Ultragenyx Presents Data on Patients With Cardiomyopathy Treated with UX007

Symbiomix Therapeutics Announces That The FDA Has Granted Fast Track Designation To Its Single-Dose Bacterial Vaginosis Therapy, SYM-1219

BlackRock Embraces Robo Finance Advice with Acquisition of FutureAdvisor

ViewRay Completes Private Placement, Raises Aggregate of $29.4Million

Tradier Offers An Alternative to Other Robo-Advisors with Build-Your-Own Digital Platform